NuVasive Inc (NUVA.OQ)
17 Jan 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|51||2015||Chairman of the Board, Chief Executive Officer|
|44||2016||President, Chief Operating Officer|
|41||2015||President - U.S. Commercial|
|50||2016||Vice Chairman of the Board|
|37||2014||Chief Financial Officer, Executive Vice President|
- BRIEF-Nuvasive sees FY 2017 revenue $1.065 bln
- BRIEF-Nuvasive repurchased about $49.6 mln in aggregate principal amount of its 2.75 PCT convertible senior notes due 2017
- BRIEF-Jana Partners cuts sole share stake in Alphabet, takes sole share stake in Mondelez International
- Federal Circuit affirms invalidity of NuVasive spine implant patent
- BRIEF-Nuvasive secures magnetic resonance FDA conditional clearance for Magec system